Concepedia

Malgosia Kania

MK

Statistics

Publications

11

Citations

729

H-Index

11

Active since

1980

Affiliations

Roche (Switzerland)(Current)

Basilea Pharmaceutica (Switzerland)

Johnson & Johnson (United States)

Washington University in St. Louis

Malgosia Kania is an author at Roche (Switzerland) specializing in life sciences, biochemistry, and enzymology.

Publications per year

1980–2007

11

Publications

11

Binding of Ceftobiprole and Comparators to the Penicillin-Binding Proteins of <i>Escherichia coli</i> , <i>Pseudomonas aeruginosa</i> , <i>Staphylococcus aureus</i> , and <i>Streptococcus pneumoniae</i>

Todd A. Davies, Malcolm G. P. Page, Wenchi Shang et al. · Antimicrobial Agents and Chemotherapy · 2007 · 162 citations · Full text

, , +13

Crystallographic and Biophysical Analysis of a Bacterial Signal Peptidase in Complex with a Lipopeptide-based Inhibitor

Mark Paetzel, Jonathon J. Goodall, Malgosia Kania et al. · Journal of Biological Chemistry · 2004 · 109 citations · Full text

, , +11

Interactions of Ceftobiprole with β-Lactamases from Molecular Classes A to D

Anne Marie Queenan, Wenchi Shang, Malgosia Kania et al. · Antimicrobial Agents and Chemotherapy · 2007 · 85 citations · Full text

, , +16

Design, Synthesis, and Evaluation of 2β-Alkenyl Penam Sulfone Acids as Inhibitors of β-Lactamases

Hans Richter, Peter Angehrn, Christian Hubschwerlen et al. · Journal of Medicinal Chemistry · 1996 · 76 citations · Full text

, , +15

Structure-Based Design of β-Lactamase Inhibitors. 1. Synthesis and Evaluation of Bridged Monobactams

Ingrid Heinze‐Krauss, Peter Angehrn, Robert L. Charnas et al. · Journal of Medicinal Chemistry · 1998 · 75 citations · Full text

, , +15

1–5 of 11